Skip to main content

Neurosurgical Interventions for Leptomeningeal Tumor

  • Chapter
Leptomeningeal Metastases

Part of the book series: Cancer Treatment and Research ((CTAR,volume 125))

Abstract

Nonsurgical modalities remain the keystone to treatment and control of leptomeningeal tumor. However, neurosurgical consultation is often required for placement of Ommaya reservoirs and ventriculoperitoneal shunts. In this chapter, the utility of these devices, as well as their common complications will be presented. The aim will be to familiarize non-surgical providers with the indications for and complications associated with these neurosurgical procedures as a component of the adjuvant treatment of leptomeningeal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pels H, Schmidt-Wolf IG, Glasmacher A, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 2003; 21:4489–95.

    Article  PubMed  CAS  Google Scholar 

  2. Esteva FJ, Soh, LT, Holmes FA, et al. Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer. Cancer Chemother Pharmacol 2000; 46:382–6.

    Article  PubMed  CAS  Google Scholar 

  3. Witham TF, Fukui MB, Meltzer CC, et al. Survival of patients with high grade glioma treated with intrathecal thio triethylenephosphoramide for ependymal or leptomeningeal gliomatosis. Cancer 1999; 86:1347–53.

    Article  PubMed  CAS  Google Scholar 

  4. Kramer K, Cheung NK, Humm JL, et al. Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8. Med Pediatr Oncol 2000; 35:716–8.

    Article  PubMed  CAS  Google Scholar 

  5. Witorsch P, Williams TW Jr, Ommaya AK, Utz JP. Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. JAMA 1965; 194:699–702.

    Article  PubMed  CAS  Google Scholar 

  6. Sandberg DI, Bilsky MH, Souweidane MM, Bzdil J, Gutin PH. Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 2000; 47:49–54.

    Article  PubMed  CAS  Google Scholar 

  7. Greenfield JP, Schwartz TH. Frameless stereotaxy for Ommaya Reservoirs. Neurosurgery 2004 [Submitted for publication].

    Google Scholar 

  8. Al-Anazi A, Bernstein M. Modified stereotactic insertion of the Ommaya reservoir. Technical note. J Neurosurg 2000; 92:1050–2.

    Article  PubMed  CAS  Google Scholar 

  9. Cheshire WP, Ehle AL. Hemiparkinsonism as a complication of an Ommaya reservoir. Case report. J. Neurosurg 1990; 73:774–6.

    Article  PubMed  CAS  Google Scholar 

  10. Galicich JH, Guido LJ. Ommaya device in carcinomatous and leukemic meningitis: surgical experience in 45 cases. Surg Clin North Am 1974; 54:915–22.

    PubMed  CAS  Google Scholar 

  11. Lishner M, Perrin RG, Feld R, et al. Complications associated with Ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature. Arch Intern Med 1990; 150:173–6.

    Article  PubMed  CAS  Google Scholar 

  12. Obbens EA, Leavens ME, Beal JW, Lee YY. Ommaya reservoirs in 387 cancer patients: a 15-year experience. Neurology 1985; 35:1274–8.

    PubMed  CAS  Google Scholar 

  13. Mehta BM, Glass JP, Shapiro WR. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis. Cancer Res 1983; 43:435–8.

    PubMed  CAS  Google Scholar 

  14. Shapiro WR, Young DF, Mehta MB. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975; 293:161–6.

    Article  PubMed  CAS  Google Scholar 

  15. Lemann W, Wiley RG, Posner JB. Leukoencephalopathy complicating intraventricular catheters: clinical, radiographic and pathologic study of 10 cases. J Neuroonc 1988; 6:67–74.

    Article  CAS  Google Scholar 

  16. Oka M, Terae S, Kobayashi R, et al. MRI in methotrexate-related leukoencephalopathy: Disseminated necrotizing leukoencephalopathy in comparison with mild leukoencephalopathy. Neuroradiology 2003; 45:493–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Greenfield, J.P., Bilsky, M.H. (2005). Neurosurgical Interventions for Leptomeningeal Tumor. In: Abrey, L.E., Chamberlain, M.C., Engelhard, H.H. (eds) Leptomeningeal Metastases. Cancer Treatment and Research, vol 125. Springer, Boston, MA. https://doi.org/10.1007/0-387-24199-X_7

Download citation

  • DOI: https://doi.org/10.1007/0-387-24199-X_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-24198-2

  • Online ISBN: 978-0-387-24199-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics